Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
West Pharmaceutical Services, Inc. Banner

West Pharmaceutical Services, Inc.

WST Stock Analysis

Page title

Section title

Dividend Score

Dividend Score ranks stocks based on metrics important to dividend investors, helping you identify companies with a history of consistent dividends and the financial strength

0

Dividend Stability

WST has maintained stable dividend payments over the past 10 years with no cuts over 5%.

Dividend Growth

WST's dividend payments have shown moderate growth, growing by 4.564% annually over the last 5 years.

Earnings Growth

WST's earnings have grown by 19.678% annually over the last 5 years. This strong earnings growth suggests a stable and increasing income stream, supporting the sustainability and potential growth of dividend payouts.

Premium Crown

Unlock Dividend Score

Upgrade to Serious Investor for a data-driven dividend score with 88% accuracy in predicting cuts, giving you a competitive advantage.

About West Pharmaceutical Services, Inc.

Medical - Instruments & Supplies
Healthcare

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products...

West Pharmaceutical Services, Inc. Key Metrics

Market Cap
$23B
52 Weeks Low
$265
52 Weeks High
$413.70
Dividend Yield
0.27%
P/E
43.62x
P/S
7.91x

Upcoming Events

    West Pharmaceutical Services, Inc. Dividends

    Dividend Yield
    0.27%
    Payout Ratio
    11.38%
    Dividend Amount Per Share
    $0.79
    Last Ex-Dividend Date
    Jul 31, 2024

    WST Dividend Safety

    WST paid out 11.38% of its $593M earnings as dividends over the last 12 months.

    Very Safe

    1. Very Unsafe

    2. Unsafe

    3. Somewhat Safe

    4. Safe

    5. Very Safe

    Dividend Payout Ratio

    WST's Dividend Payout Ratio of 11.383% is considered safe for the Healthcare sector, indicating that the company retains enough earnings to support business growth.

    Interest Rate Coverage

    WST's Interest Coverage Ratio of 82.194 indicates strong financial health with easy coverage of interest expenses.

    Income Quality

    WST shows excellent income quality with a ratio of 1.309. This indicates high-quality earnings and low risk of dividend cuts.

    WST Dividend Growth

    West Pharmaceutical Services, Inc.(WST) offers a dividend yield of 0.27% and pays $0.79 in dividends per share. Explore the historical dividend growth of WST.

    Dividend Stability

    WST has maintained stable dividend payments over the past 10 years with no cuts over 5%.

    Dividend Growth

    WST's dividend payments have shown moderate growth, growing by 4.564% annually over the last 5 years.

    Earnings Growth

    WST's earnings have grown by 19.678% annually over the last 5 years. This strong earnings growth suggests a stable and increasing income stream, supporting the sustainability and potential growth of dividend payouts.

    WST Analyst Forecasts



    WST Financials

    WST Income Statement Key Metrics

    • Revenue(TTM)2.88 B
    • Gross Profit(TTM)1.03 B
    • EBITDA(TTM)760.70 M
    • Net Income(TTM)524.90 M
    • EPS Diluted(TTM)7.030000000000001

    Decode WST's Latest Earnings Call with Ease

    Tap 'Generate' for a crystal-clear,
    AI-crafted summary and stay ahead in the investment game!

    WST earnings and revenue history

    Gross Profit Margin vs Peers

    Profit margin ratio of WST (0.383) is lower than the average of its peers (0.497).

    Net Profit Margin vs Peers

    Net profit margin ratio of WST (0.201) is higher than the average of its peers (0.097).

    WST Return on Equity

    See how efficiently WST generates profit for it's shareholders.

    20.60%

    10
    0
    100
    1. Poor

    2. Average

    3. Strong

    Return on Equity vs Peers

    Return on Equity ratio of WST (0.206) is higher than the average of its peers (0.080).

    Return on Equity Growth

    WST's Return on Equity has shown poor growth over the past 10 years, increasing by only 4.48%.

    WST Revenue Growth

    See how WST has grown it's revenue over the past 10 years.


    Revenue Growth

    WST's revenue has shown poor growth over the past 10 years, increasing by only 7.57%.